GlaxoSmithKline plc Share Price LIQUIDNET SYSTEMS
Stocks
GSK
GB0009252882
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-0.40% | - |
| 19/06 | Moderna Secures Favorable FDA Panel Recommendation for mRNA Flu Vaccine | |
| 18/06 | The Gulf Gives, the Fed Takes |
| Market Cap | 7.68TCr 10TCr 8.85TCr 8.16TCr 14TCr 9,57600Cr 14TCr 97TCr 38TCr 4,71900Cr 38TCr 37TCr 16,35700Cr | P/E 2026 * |
12.3x | P/E 2027 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.18TCr 12TCr 11TCr 9.76TCr 17TCr 11,44800Cr 17TCr 1,16100Cr 45TCr 5,64100Cr 46TCr 45TCr 19,55400Cr | EV / Sales 2026 * |
2.72x | EV / Sales 2027 * | 2.5x |
| Free-Float |
92.29% | Yield 2026 * |
3.74% | Yield 2027 * | 3.96% |
Last Transcript: GlaxoSmithKline plc
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -0.40% | - | - | 10TCr | ||
| -1.21% | -5.37% | +39.94% | +145.38% | 98TCr | ||
| -2.48% | -4.17% | +51.52% | +39.07% | 55TCr | ||
| -2.14% | -3.68% | +16.71% | +56.15% | 38TCr | ||
| -2.28% | +0.25% | +25.86% | +16.53% | 32TCr | ||
| +1.31% | -1.13% | +26.14% | +14.29% | 27TCr | ||
| +1.13% | -2.20% | +25.41% | +31.43% | 27TCr | ||
| +5.06% | +2.18% | -39.91% | -45.79% | 19TCr | ||
| -1.19% | -4.65% | +16.56% | +47.00% | 18TCr | ||
| -1.35% | -1.68% | +14.59% | +56.94% | 15TCr | ||
| Average | -0.32% | -2.68% | +19.65% | +40.11% | 36.6TCr | |
| Weighted average by Cap. | -0.85% | -3.38% | +28.41% | +64.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.38TCr 4.47TCr 3.9TCr 3.59TCr 6.32TCr 4,21600Cr 6.37TCr 43TCr 17TCr 2,07800Cr 17TCr 16TCr 7,20100Cr | 3.55TCr 4.7TCr 4.09TCr 3.77TCr 6.64TCr 4,42600Cr 6.68TCr 45TCr 17TCr 2,18100Cr 18TCr 17TCr 7,56000Cr |
| Net income | 626.62Cr 829.44Cr 722.69Cr 666.2Cr 1.17TCr 78TCr 1.18TCr 7.93TCr 3.08TCr 39TCr 3.11TCr 3.05TCr 1,33500Cr | 666.92Cr 882.78Cr 769.16Cr 709.04Cr 1.25TCr 83TCr 1.26TCr 8.44TCr 3.28TCr 41TCr 3.31TCr 3.24TCr 1,42100Cr |
| Net Debt | 1.5TCr 1.99TCr 1.73TCr 1.59TCr 2.81TCr 1,87100Cr 2.83TCr 19TCr 7.37TCr 92TCr 7.45TCr 7.29TCr 3,19600Cr | 1.19TCr 1.58TCr 1.38TCr 1.27TCr 2.23TCr 1,48900Cr 2.25TCr 15TCr 5.86TCr 73TCr 5.93TCr 5.8TCr 2,54300Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions



















